Hayes D L, Graham K J, Irwin M, Vidaillet H, Disler G, Sweesy M, Osborn M J, Suman V J, Neubauer S A, Seebandt M
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905.
Pacing Clin Electrophysiol. 1992 Jul;15(7):1033-9. doi: 10.1111/j.1540-8159.1992.tb03097.x.
A multicenter study was undertaken to determine the failure rate of a specific polyurethane bipolar tined pacing lead, the Medtronic 4012 pacing lead. Six centers in the United States and Canada implanted 1,190 Medtronic 4012 pacing leads. The study was designed to determine the probability and clinical manifestations of lead failure. Only failures compatible with an insulation problem were included. The probability of a 4012 lead failure by Kaplan-Meier analysis was 20.9% at 6 years after implantation. Failures were manifested as sensing abnormalities, failure to capture, early battery depletion, and significant decrease in measured impedance compared with the previous impedance measurements. Of the 95 definite lead failures, 16 (16.8%) were associated with symptoms similar to those experienced before pacemaker placement. The observed failure rate is unacceptable, and strong consideration should be given to replacing the 4012 pacing lead in pacemaker-dependent patients and closely monitoring nondependent patients.
一项多中心研究旨在确定特定的聚氨酯双极翼状起搏导线(美敦力4012起搏导线)的故障率。美国和加拿大的六个中心植入了1190根美敦力4012起搏导线。该研究旨在确定导线故障的概率和临床表现。仅纳入与绝缘问题相符的故障。通过Kaplan-Meier分析,植入后6年时4012导线故障的概率为20.9%。故障表现为感知异常、夺获失败、早期电池耗尽以及与先前阻抗测量相比测量阻抗显著降低。在95例明确的导线故障中,16例(16.8%)伴有与起搏器植入前相似的症状。观察到的故障率是不可接受的,对于依赖起搏器的患者,应强烈考虑更换4012起搏导线,并对不依赖起搏器的患者进行密切监测。